Overview
- The Norwegian Royal House confirmed on Wednesday that Crown Princess Mette‑Marit underwent a lung transplant at Oslo University Hospital’s Rikshospitalet and doctors say the procedure has been successful so far.
- Treating physicians said the princess will remain in hospital for several weeks for medication adjustment, monitoring and rehabilitation, with further updates deferred until discharge.
- Palace and hospital officials declined to disclose the exact timing or donor identity for legal and privacy reasons and said organ allocation followed standard medical criteria, not status.
- Public disclosure that she was placed on the transplant waiting list triggered a sharp rise in registrations for organ donation in Norway, with reports of about 12,000 new sign‑ups.
- Doctors warned that lung transplants carry significant long‑term risks, require lifelong immunosuppression and offer variable survival outcomes, while Norway’s presumed‑consent system and Scandiatransplant sharing affect how scarce donor lungs are matched and distributed.